Scientists finally reveal how this Alzheimer’s drug really works

A key Alzheimer’s drug has finally revealed its secret. Researchers discovered that lecanemab works by activating the brain’s immune cells—but only through a specific part of the antibody called the Fc fragment. This piece acts like a trigger, prompting microglia to clear harmful amyloid plaques. The finding could reshape how future Alzheimer’s therapies are designed.

This story was reported by Healthy Aging News -- ScienceDaily. EUROPES curates Europe's most relevant coverage — read the full report at the original source.